CEOs’ Fireside Chat
Time: 11:00 am
day: Pre-Conference Day AM
Details:
With the next wave of mRNA medicines approaching, and companies who were involved pre- pandemic now utilising
validated platforms to develop new therapeutics and vaccines, this leads to the inevitable question: What comes next?
We now need to realise the opportunities of such mRNA- based therapeutic applications, as we hear from the leaders of the field on the future of this technology.
- What does the future look like for the next generation of mRNA- based therapeutics for clinically relevant targets?
- Where do we expect new innovations to come from, and what challenges lie ahead of us?
- What limits actual development, where mRNA could be leveraged to replace existing technologies?
